On ECHEMI
Home > Drugs > Hainan General Sanyang Pharmaceutical Co., Ltd.
Hainan General Sanyang Pharmaceutical Co., Ltd.
  • Founded in:

    2001-08-20
  • Country:

    China China
  • Address:

    No. 8 Haili Road, Xiuying District, Haikou City
  • Tax NO.:

    91460000730051264Q
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Ceftriaxone Sodium for Injection
The main ingredient of this product is ceftriaxone sodium.
Name Description Content CAS NO. Registered Holders
Cefotaxime sodium

This product is an antibiotic drug. Except for enterococci, methicillin-resistant and penicillin-resistant Staphylococcus aureus, this product has good antibacterial activity against other Gram-positive cocci. Pneumococci and lytic streptococci are highly sensitive to this product. Diphtheria Corynebacterium, anthrax Bacillus, Listeria and Clostridium are sensitive to this drug. This product has stronger antibacterial activity against Escherichia coli, Proteus mirabilis and Klebsiella pneumoniae than cephalothin and cefotaxime, but its antibacterial effect against high-content bacteria is poorer than the latter two. Salmonella typhi and Shigella are sensitive to this drug, while other Enterobacteriaceae, Acinetobacter and Pseudomonas aeruginosa and Bacteroides fragilis are resistant. Neisseria is quite sensitive to this product, while influenza bacilli are only moderately sensitive.

More

This product is an antibiotic drug. Except for enterococci, methicillin-resistant and penicillin-resistant Staphylococcus aureus, this product has good antibacterial activity against other Gram-positive cocci. Pneumococci and lytic streptococci are highly sensitive to this product. Diphtheria Corynebacterium, anthrax Bacillus, Listeria and Clostridium are sensitive to this drug. This product has stronger antibacterial activity against Escherichia coli, Proteus mirabilis and Klebsiella pneumoniae than cephalothin and cefotaxime, but its antibacterial effect against high-content bacteria is poorer than the latter two. Salmonella typhi and Shigella are sensitive to this drug, while other Enterobacteriaceae, Acinetobacter and Pseudomonas aeruginosa and Bacteroides fragilis are resistant. Neisseria is quite sensitive to this product, while influenza bacilli are only moderately sensitive.

64485-93-4 44
Cefoxitin Sodium for Injection
The main ingredient of this product is cefoxitin sodium, and its other scientific name is: (6R,7S)-3-carbamoyloxymethyl-7-methoxy-8-oxo-7-[2(2-thienyl)acetylamino]-5-thia-1-azabicyclo-[4.2.0]oct-2-ene-2-carboxylic acid sodium salt.
Name Description Content CAS NO. Registered Holders
Cefoxitin sodium

It kills bacteria by inhibiting bacterial cell wall synthesis and has high resistance to β-lactamase produced by bacteria. Some common Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product. It is resistant to Pseudomonas aeruginosa, most strains of enterococci, and Escherichia coli.

More

It kills bacteria by inhibiting bacterial cell wall synthesis and has high resistance to β-lactamase produced by bacteria. Some common Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product. It is resistant to Pseudomonas aeruginosa, most strains of enterococci, and Escherichia coli.

33564-30-6 23
Cefoxitin Sodium for Injection
The main ingredient of this product is cefoxitin sodium, and its other scientific name is: (6R,7S)-3-carbamoyloxymethyl-7-methoxy-8-oxo-7-[2(2-thienyl)acetylamino]-5-thia-1-azabicyclo-[4.2.0]oct-2-ene-2-carboxylic acid sodium salt.
Name Description Content CAS NO. Registered Holders
Cefoxitin sodium

It kills bacteria by inhibiting bacterial cell wall synthesis and has high resistance to β-lactamase produced by bacteria. Some common Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product. It is resistant to Pseudomonas aeruginosa, most strains of enterococci, and Escherichia coli.

More

It kills bacteria by inhibiting bacterial cell wall synthesis and has high resistance to β-lactamase produced by bacteria. Some common Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product. It is resistant to Pseudomonas aeruginosa, most strains of enterococci, and Escherichia coli.

33564-30-6 23
Cefoxitin Sodium for Injection
The main ingredient of this product is cefoxitin sodium, and its other scientific name is: (6R,7S)-3-carbamoyloxymethyl-7-methoxy-8-oxo-7-[2(2-thienyl)acetylamino]-5-thia-1-azabicyclo-[4.2.0]oct-2-ene-2-carboxylic acid sodium salt.
Name Description Content CAS NO. Registered Holders
Cefoxitin sodium

It kills bacteria by inhibiting bacterial cell wall synthesis and has high resistance to β-lactamase produced by bacteria. Some common Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product. It is resistant to Pseudomonas aeruginosa, most strains of enterococci, and Escherichia coli.

More

It kills bacteria by inhibiting bacterial cell wall synthesis and has high resistance to β-lactamase produced by bacteria. Some common Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product. It is resistant to Pseudomonas aeruginosa, most strains of enterococci, and Escherichia coli.

33564-30-6 23
Lysine aspirin for injection
The main ingredients of this product are: Lysine
Name Description Content CAS NO. Registered Holders
DL-Lysine acetylsalicylate

This product is a complex salt of aspirin and lysine, which can inhibit cyclooxygenase, reduce the synthesis of prostaglandins, and has antipyretic, analgesic and anti-inflammatory effects.

More

This product is a complex salt of aspirin and lysine, which can inhibit cyclooxygenase, reduce the synthesis of prostaglandins, and has antipyretic, analgesic and anti-inflammatory effects.

62952-06-1 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.